Investor Presentaiton

Revenue structure and project pipeline Innovation - excellence – trust H1 2021 revenue split (EUR 135 m) - Metabolic Gastrologic Oncologic Cardio- and neurologic Other Large pharma Biotech Other pharma & academia Custom Projects Contract Manufacturing Generics & Cosmetics # of custom projects Pre-clinical Phase I Phase II Phase III GLOBAL SUPPORT FOR A QUALITY SOLUTION Helping patients accross multiple deseases Revenue structure by therapeutic areas Servicing a diversified customer base Revenue structure by customer type Providing solutions along product phases Revenue structure by business segment Focusing on innovation Number of custom projects by stage of development 11 PolyPeptide GROUP

View entire presentation